RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
MedCap AB (publ) Stock

MedCap AB (publ) Market capitalization 2024

MedCap AB (publ) Market capitalization

7.55 B SEK

Ticker

MCAP.ST

ISIN

SE0009160872

WKN

A2ASQ7

In 2024, MedCap AB (publ)'s market cap stood at 7.55 B SEK, a 89.41% increase from the 3.98 B SEK market cap in the previous year.

The MedCap AB (publ) Market capitalization history

YEARMarket Capitalization (undefined SEK)
20234.08
20222.75
20213.01
20202.56
20191.46
20181.03
20170.46
20160.44
20150.33
20140.49
20130.32
20120.2
20110.19
20100.15
20090.09
2008-
2007-
2006-
2005-
2004-

MedCap AB (publ) Aktienanalyse

What does MedCap AB (publ) do?

MedCap AB (publ) is a Swedish company specializing in the development and marketing of medical products. The company was founded in 2006 by a group of experts in the medical industry. MedCap's business model is focused on developing and marketing innovative medical products. The company has two main business areas: Medical Devices and Diagnostics. In the Medical Devices area, MedCap develops products for various medical applications, including respiratory diseases, pain therapy, and wound care. In the Diagnostics area, the company offers diagnostic tests for various diseases, including infectious diseases and cancer. MedCap aims to improve medical care through innovative products. The company has introduced a range of groundbreaking products that offer higher effectiveness and more convenient use for patients. An example of a MedCap product is the Aeroneb® Pro. This is an advanced nebulizer device used for the treatment of respiratory diseases such as asthma, COPD, and cystic fibrosis. According to MedCap, the Aeroneb® Pro is the most effective nebulizer device of its kind, offering higher medication absorption through the lungs than other nebulizer devices. Another MedCap product is the ClipOn® Pain Relief. This is a portable pain reliever used to alleviate pain from various diseases such as arthritis and back pain. According to MedCap, the ClipOn® Pain Relief is a fast and safe way to relieve pain and improve patients' quality of life. In the Diagnostics area, MedCap offers a range of diagnostic tests for infectious diseases, including HIV, hepatitis, and tuberculosis. An example of a MedCap diagnostic test is the Diagnostics Quick Test (DQT), a rapid test for HIV detection. According to MedCap, the DQT is the fastest HIV test on the market, providing results in just 15 minutes. MedCap has also focused on the field of personalized medicine. The company has developed a platform called Confero that enables doctors to offer personalized medicine to their patients. Confero utilizes artificial intelligence and machine learning to provide accurate diagnosis and treatment for each patient. Overall, MedCap has established itself as a leading company in the medical industry, offering innovative products and services for medical care. The company has a strong presence in Europe and is also expanding into other parts of the world. MedCap aims to improve medical care through its products and services, making a positive impact on the lives of patients. MedCap AB (publ) ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Market capitalization Details

Exploring MedCap AB (publ)'s Market Capitalization

MedCap AB (publ)'s market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of MedCap AB (publ)'s market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

MedCap AB (publ)'s market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in MedCap AB (publ)’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about MedCap AB (publ) stock

What is the current MedCap AB (publ) market capitalization?

The current market capitalization of MedCap AB (publ) is 7.55 B SEK.

What is market capitalization?

The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like MedCap AB (publ).

How has the market capitalization of MedCap AB (publ) developed in recent years?

The market capitalization of MedCap AB (publ) has increased/decreased by 89.41% compared to the previous year.

What does market capitalization mean for investors?

The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.

Why is market capitalization an important indicator for investors?

The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.

Why does the market capitalization fluctuate?

The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.

What role does market capitalization play in the valuation of MedCap AB (publ)?

In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.

Does the market capitalization influence the performance of MedCap AB (publ)?

There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

Does the market capitalization of MedCap AB (publ) have an influence on indices?

Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).

How much dividend does MedCap AB (publ) pay?

Over the past 12 months, MedCap AB (publ) paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MedCap AB (publ) is expected to pay a dividend of 0 SEK.

What is the dividend yield of MedCap AB (publ)?

The current dividend yield of MedCap AB (publ) is .

When does MedCap AB (publ) pay dividends?

MedCap AB (publ) pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of MedCap AB (publ)?

MedCap AB (publ) paid dividends every year for the past 0 years.

What is the dividend of MedCap AB (publ)?

For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.

In which sector is MedCap AB (publ) located?

MedCap AB (publ) is assigned to the 'Health' sector.

Wann musste ich die Aktien von MedCap AB (publ) kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of MedCap AB (publ) from 9/17/2024 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.

When did MedCap AB (publ) pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of MedCap AB (publ) in the year 2023?

In the year 2023, MedCap AB (publ) distributed 0 SEK as dividends.

In which currency does MedCap AB (publ) pay out the dividend?

The dividends of MedCap AB (publ) are distributed in SEK.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von MedCap AB (publ)

Our stock analysis for MedCap AB (publ) Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MedCap AB (publ) Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.